| Diane Houston |
Diane Houston is currently the Vice President-Global Information Technology at Harvard Bioscience, Inc. Previously, she worked as the Senior Director-Applications at Haemonetics Corp. from 2016 to 2018. Ms. Houston completed her undergraduate degree at the University of San Francisco. |
| David Balcom |
David Balcom is currently the Senior Vice President-Operations at Harvard Bioscience, Inc. He previously held the same position at Cirtec Medical Systems LLC. Mr. Balcom has an undergraduate degree from the US Military Academy and holds an MBA from both the University of Colorado Colorado Springs and the University of Colorado. |
| Jennifer Cote |
Jennifer Cote is currently the Treasurer, Chief Financial & Accounting Officer at Harvard Bioscience, Inc. Prior to her current position, she worked at Bose Corp. as the Head-Financial, Strategy & Operations from 1999 to 2022. She also served as an Audit Manager at Arthur Andersen LLP. Ms. Cote completed her undergraduate degree at Villanova University and furthered her education at Villanova School of Business. |
| James W. Green |
James W. Green's current job(s) include being the Chairman, President & Chief Executive Officer at Harvard Bioscience, Inc., a Director at Ultrasonix Medical Corp., and the President & Director at Copley Controls Corp. Formerly, Mr. Green held positions such as President, Chief Executive Officer & Director at Analogic Corp. and Analogic Canada Corp., SVP & GM-Global Computer Tomography Business at Koninklijke Philips NV, Regional Vice President at Unilab Corp. and Quest Diagnostics, Inc., President at Spacelabs Healthcare, Inc., Senior Vice President & General Manager at Philips Medical Systems, Senior Vice President-Product Development at Marconi Medical Systems, Inc., and General Partner at Grantchester Group Ltd.Mr. Green obtained a graduate degree from the University of Southern California and an undergraduate degree from the University of Missouri. |
| Katherine A. Eade |
Katherine A. Eade is an Independent Director at Harvard Bioscience, Inc. She previously worked as the Director-M&A Law at Corning, Inc. from 2009 to 2018. She also served as an Independent Director at Vaxxinity, Inc. in 2023. In addition, Katherine was the Deputy General Counsel at La-Z-Boy, Inc. from 2018 to 2019 and the Vice President-Strategic Commercial Affairs at Align Technology, Inc. from 2019 to 2020. Prior to that, she worked as an Attorney at Cleary Gottlieb Steen & Hamilton LLP from 2001 to 2009. Katherine also served as the General Counsel at Checkmate Pharmaceuticals, Inc. from 2020 to 2022. She has a background in law, having obtained her undergraduate degree from Cornell University and her graduate degree from Harvard Law School. |
| Alan I. Edrick |
Alan I. Edrick is currently serving as a Director at American Science & Engineering, Inc., an Independent Director at Harvard Bioscience, Inc., and as the Chief Financial Officer & Executive VP at OSI Systems, Inc. He also served as the Chief Financial Officer at Spacelabs Healthcare, Inc. in the past. Prior to his current positions, he worked as a Director at Vertical Branding, Inc., Chief Financial Officer & Executive Vice President at Biosource International, Inc., Chief Financial Officer & Senior Vice President at North American Scientific, Inc., and Senior Manager-Capital Markets at Pricewaterhouse LLP. Edrick holds an undergraduate degree from the University of California, Los Angeles, and an MBA from UCLA Anderson School of Management, which he received in 2002. |
| Bertrand Loy |
Bertrand Loy is currently the Chairman, President & Chief Executive Officer at Entegris, Inc. He is also the Chief Executive Officer at QED Technologies International, Inc. In addition, he holds the position of President & Director at ATMI, Inc. and Director at CMC Materials LLC. Mr. Loy is the Lead Independent Director at Harvard Bioscience, Inc. He is also a Director at Massachusetts High Technology Council, Inc. Furthermore, he serves as the Co-Managing Director at Entegris GmbH and is a Member-Supervisory Board at Hangzhou Anow Microfiltration Co., Ltd.Mr. Loy previously served as the Chairman of Semiconductor Equipment & Materials International from 2012 to 2023. He was an Independent Director at BTU International, Inc. from 2010 to 2015. Mr. Loy also held the position of Chief Information Officer at EMD Millipore Corp. from 1995 to 2000 and Chief Financial Officer & Vice President at Mykrolis Corp. from 2001 to 2005. Mr. Loy obtained an MBA from ESSEC Business School. |
| Thomas W. Loewald |
Thomas W. Loewald is currently the President & Chief Executive Officer at Cambrex Corp. He is also an Independent Director at Harvard Bioscience, Inc. and a Director at the National Association of Manufacturers. In his former positions, Loewald served as the Marketing Director at GE Aerospace and as a Financial Analyst at Goldman Sachs & Co. LLC. He was the Chief Commercial Officer & Senior Vice President at Thermo Fisher Scientific, Inc. from 2012 to 2017. Prior to that, he was the Vice President-Sales & Marketing at Tyco International (US), Inc. from 1998 to 2002. Loewald also served as the President-Flexible Packaging Division at ProAmpac LLC from 2017 to 2020. Loewald completed his undergraduate studies at Middlebury College and holds an MBA from the Tuck School of Business at Dartmouth. |
